Text Size
10 studies found for:    ( Phentermine AND Topiramate ) [TREATMENT] AND Obesity [DISEASE]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults
Condition: Obesity
Interventions: Drug: topiramate;   Drug: phentermine
2 Not yet recruiting Peripheral Pharmacodynamics of Phentermine_Topiramate in Obese Patients
Condition: Obesity
Interventions: Drug: Phentermine-Topiramate;   Drug: Matched-Placebo
3 Completed
Has Results 		A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in Adults
Condition: Obesity
Interventions: Drug: VI-0521;   Drug: topiramate;   Drug: phentermine
4 Completed
Has Results 		Study of VI-0521 Compared to Placebo in Treatment of Obesity in Adults
Condition: Obesity
Interventions: Drug: VI-0521;   Drug: Placebo matched phentermine/topiramate
5 Completed
Has Results 		A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)
Condition: Obesity
Interventions: Drug: VI-0521;   Drug: Placebo
6 Completed A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.
Conditions: Overweight;   Obesity
Interventions: Drug: VI-0521;   Drug: Placebo;   Other: Alcohol or fruit juice
7 Completed A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.
Condition: Obesity
Intervention: Drug: Metformin, VI-0521, Sitagliptan, Probenecid
8 Completed
Has Results 		A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese Adults
Condition: Sleep Apnea
Interventions: Drug: VI-0521;   Drug: placebo
9 Completed
Has Results 		Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: VI-0521;   Drug: Placebo
10 Completed
Has Results 		Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions
Conditions: Obesity;   Type 2 Diabetes
Intervention: Drug: VI-0521
To Top

† Indicates status has not been verified in more than two years